Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taiwan - Delayed Quote TWD

Sinphar Pharmaceutical Co.,Ltd. (1734.TW)

Compare
31.05
0.00
(0.00%)
At close: April 2 at 1:30:20 PM GMT+8
Loading Chart for 1734.TW
  • Previous Close 31.05
  • Open 31.00
  • Bid 31.00 x --
  • Ask 31.10 x --
  • Day's Range 30.75 - 31.10
  • 52 Week Range 28.60 - 36.30
  • Volume 132,208
  • Avg. Volume 160,650
  • Market Cap (intraday) 5.624B
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) 18.48
  • EPS (TTM) 1.68
  • Earnings Date --
  • Forward Dividend & Yield 1.00 (3.22%)
  • Ex-Dividend Date Sep 4, 2024
  • 1y Target Est 31.00

Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, including antineoplastic, ophthalmic, ENT, oral, respiratory system, dermatology, analgesic and NSAIDs, metabolic and nutrient, gastrointestinal, and other products; and healthy food under the Sinphar, DailyCare, Migus, YouBest, and SynCoreBio brands. It also provides moisturizer repair essence, anti aging cream, renewable oi, and UV defence cream under the DYNASKIN brand; serum, revitalizing cream, hygiene, sunblock, sunscreen, and lightening tables under the Yestuner brand; and shower gel and hair shampoo. In addition, the company is involved in the provision of testing and development, as well as product design and manufacturing services. The company was incorporated in 1977 and is based in Yilan City, Taiwan.

www.sinphar.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 1734.TW

View More

Performance Overview: 1734.TW

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

1734.TW
0.48%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
7.54%

1-Year Return

1734.TW
6.02%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
4.06%

3-Year Return

1734.TW
26.65%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
20.84%

5-Year Return

1734.TW
116.41%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
120.40%

Compare To: 1734.TW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1734.TW

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    5.62B

  • Enterprise Value

    6.35B

  • Trailing P/E

    18.48

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.79

  • Price/Book (mrq)

    1.72

  • Enterprise Value/Revenue

    2.02

  • Enterprise Value/EBITDA

    10.56

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.67%

  • Return on Assets (ttm)

    2.96%

  • Return on Equity (ttm)

    8.22%

  • Revenue (ttm)

    3.15B

  • Net Income Avi to Common (ttm)

    304.7M

  • Diluted EPS (ttm)

    1.68

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.18B

  • Total Debt/Equity (mrq)

    53.65%

  • Levered Free Cash Flow (ttm)

    232.08M

Research Analysis: 1734.TW

View More

Company Insights: 1734.TW

Research Reports: 1734.TW

View More

People Also Watch